253 related articles for article (PubMed ID: 10740367)
1. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
Craig S; Morris K; Tubman T; McClure B
Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
[TBL] [Abstract][Full Text] [Related]
2. The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.
Chandrasekar A; Morris KG; Tubman TR; Tharma S; McClelland WM
Ulster Med J; 2001 Nov; 70(2):89-94. PubMed ID: 11795772
[TBL] [Abstract][Full Text] [Related]
3. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
[TBL] [Abstract][Full Text] [Related]
4. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
Craig JS; McClure BG; Tubman TR
BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
[No Abstract] [Full Text] [Related]
5. Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.
Tiblad E; Westgren M; Pasupathy D; Karlsson A; Wikman AT
Acta Obstet Gynecol Scand; 2013 Sep; 92(9):1079-85. PubMed ID: 23750781
[TBL] [Abstract][Full Text] [Related]
6. The pregnant Rhesus negative Nigerian woman.
Kotila TR; Odukogbe AA; Okunlola MA; Olayemi O; Obisesan KA
Niger Postgrad Med J; 2005 Dec; 12(4):305-7. PubMed ID: 16380744
[TBL] [Abstract][Full Text] [Related]
7. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
Koelewijn JM; de Haas M; Vrijkotte TG; Bonsel GJ; van der Schoot CE
Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
[TBL] [Abstract][Full Text] [Related]
8. Routine antenatal anti-D prophylaxis and patient compliance with the two-dose regimen.
Chaffe B; Ford J; Bills V
Transfus Med; 2007 Oct; 17(5):399-403. PubMed ID: 17903141
[TBL] [Abstract][Full Text] [Related]
9. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiology of anti-D allo-immunization during pregnancy].
Branger B; Winer N
J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S87-1S92. PubMed ID: 16495833
[TBL] [Abstract][Full Text] [Related]
11. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
[TBL] [Abstract][Full Text] [Related]
12. [Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].
Katsulov A
Akush Ginekol (Sofiia); 1997; 36(2):1-2. PubMed ID: 9471891
[No Abstract] [Full Text] [Related]
13. Causes and clinical consequences of Rhesus (D) haemolytic disease of the newborn: a study of a Scottish population, 1985-1990.
Hughes RG; Craig JI; Murphy WG; Greer IA
Br J Obstet Gynaecol; 1994 Apr; 101(4):297-300. PubMed ID: 8199074
[TBL] [Abstract][Full Text] [Related]
14. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
Miquel E; Cavelier B; Bonneau JC; Rouger P
Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
[TBL] [Abstract][Full Text] [Related]
15. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
Kumpel BM
Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
[No Abstract] [Full Text] [Related]
16. Haemolytic disease of the newborn: the new NICE guidelines.
Thompson J
J Fam Health Care; 2002; 12(5):133-6. PubMed ID: 12449064
[TBL] [Abstract][Full Text] [Related]
17. A review of maternal alloimmunisation to Rh D in Northern Ireland.
McCauley CJ; Morris K; Maguire K
Transfus Med; 2017 Apr; 27(2):132-135. PubMed ID: 28101958
[TBL] [Abstract][Full Text] [Related]
18. The investigation of infants with RhD-negative mothers: can we safely omit the umbilical cord blood direct antiglobulin test?
James RM; McGuire W; Smith DP
Arch Dis Child Fetal Neonatal Ed; 2011 Jul; 96(4):F301-4. PubMed ID: 20659940
[TBL] [Abstract][Full Text] [Related]
19. [Rhesus prophylaxis--history and current status].
Behrens O; Lellé RJ
Zentralbl Gynakol; 1997; 119(5):204-10. PubMed ID: 9281253
[TBL] [Abstract][Full Text] [Related]
20. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
